The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development (R&D) organization that develops and delivers new treatments for neglected diseases that affect millions of the world’s poorest people. Together with more than 200 public research and industry allies worldwide, we use the power of partnership, innovation, open science, and advocacy to find solutions to a great injustice: the lack of medicines for life-threatening diseases that disproportionately impact poor and marginalized people.

UMEDICA is a manufacturer and exporter of Pharmaceutical Formulations viz; Injectable, Tablets, Capsules, Suspensions, Dry Syrups, etc. Since our inception in 1982, we have established ourselves as a company delivering products meeting international quality standards. We are having approval of USFDA, EU, TGA and various countries viz; Zimbave, Uganda, Improving Human Health Worldwide Kenya, Ghana, ivory Coast Malawi etc.

GlaxoSmithKline plc announced that ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi & Co. Limited Shionogi as shareholders, has agreed to settle the global patent infringement litigation between GSK, Shionogi and Gilead Sciences, Inc. Gilead concerning ViiV Healthcares patents relating to dolutegravir, an antiretroviral medication used, together with other medicines, to treat human immunodeficiency virus.

Pfizer Inc and BioNTech SE announced that following a request from the U.S. Food and Drug Administration the companies have initiated a rolling submission seeking to amend the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine to include children 6 months through 4 years of age 6 months to <5 years of age, in response to the urgent public health need in this population. The companies expect to complete the EUA submission in the coming days.

Alembic Pharmaceuticals Limited announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Fesoterodine Fumarate Extended- Release Tablets, 4 mg and 8 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Toviaz Extended-Release Tablets, 4 mg and 8 mg, of Pfizer Inc. (Pfizer).

The clinical and imaging characteristics of COVID-19 breakthrough infections in fully vaccinated patients tend to be milder than those of partially vaccinated or unvaccinated patients, according to a new multicenter study published in the journal Radiology.

The number of confirmed COVID-19 cases worldwide now exceeds 270 million with an overall mortality rate of approximately 2%.

Pharmacy Council of India proposed to the principal secretary, Health or technical education of all states and union territories that M.Pharm pharmacy practice to be included as qualification for clinical pharmacist besides Pharm.D.

The Pharmacy Council of India (PCI) is a statutory body working under the Ministry of Health and Family Welfare. Government of India, New Delhi. It is constituted under the Pharmacy Act, 1948 to regulate the profession and practice of pharmacy in the country.

National Chemical Laboratory Pune, established in 1950, is a constituent laboratory of Council of Scientific and Industrial Research (CSIR). CSIR-NCL is a science and knowledge based research, development and consulting organization. It is internationally known for its excellence in scientific research in chemistry and chemical engineering as well as for its outstanding track record of industrial research involving partnerships with industry from concept to commercialization.

Tata Memorial Centre is an autonomous grant-in-aid institution of the Department of Atomic Energy. TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH). ACTREC conducts a Ph.D. program in Life Sciences, affiliated to the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt of India). On-going research at ACTREC includes basic and translational research in Cancer Biology.

Nizam's Institute of Medical Sciences, formerly Nizams Orthopaedic Hospital, is a public hospital located in Hyderabad, Telangana, India. It is an Institute under State Legislature Act under the Act of Andhra Pradesh State Legislature. It has campuses in Punjagutta and Bibinagar.

Applications are invited from suitably qualified and experienced candidates in the prescribed format as enclosed herewith for the temporary posts mentioned below in “Medical Genetics Lab”:

Government decided to establish a Central Institute for Rice Research and this led to establishment of the Central Rice Research Institute (CRRI) on April 23, 1946 at Bidyadharpur, Cuttack, Odisha with an experimental farm land of 60 hectares provided by the Government of Odisha. Dr. K Ramiah, an eminent rice breeder, was its founder Director. Subsequently, in 1966, the administrative control of the Institute was transferred to the Indian Council of Agricultural Research (ICAR).

MORADABAD EDUCATIONAL TRUST (MET) was established in the year 1996 and started 4 years degree course in Pharmacy in the year 2009 (B. Pharm) under the banner of Faculty of Pharmacy. Subsequently Diploma in Pharmacy will start from the Academic Session 2018-19. The Institute is situated on the bank of holy river Ram Ganga in the Brass city of India (Moradabad). The College is approved by AICTE, PCI, New Delhi and affiliated to Dr. A. P. J. Abdul Kalam Technical University, Lucknow and Board of Technical Education, Lucknow.

SVN has emerged as a Centre of excellence of higher education in Uttar Pradesh. This group of Institutions has started carving a position for itself in the education domain and is rising as a shining star on the horizon of quality education. SVN has a multi-disciplinary approach and offers courses in various streams encompassing Engineering, Management, Pharmacy, Polytechnic and Diploma in Elementary Education.

Sri Lakshmi Venkateswara Institute of Pharmaceutical Sciences established in the year 2008-09 under the aegis of Sri Sudarshan Ramanujacharula Educational Society is one of the premier pharmacy colleges imparting quality pharmaceutical education and training in India. The College is located in a beautiful campus in Peddasettypalli, Proddatur. The journey of SLVP has begun in year 2008 with B.Pharmacy programme.

The inspiration behind Vishveshwarya Group of Institutions has been the renowned engineer Sir M. Visvesvaraya. The VGI was established in the year 2000 with a vision to nurture globally competent professionals in Technical and Management education. In order to diversify expertise of students multidiciplinary domains, We expanded our wings into the fields of Pharmacy, Agriculture, Education , Law,  Mass Communication & Journalism and Fashion Design.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar.

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

IQVIA is the leading human data science company focused on helping healthcare clients find unparalleled insights and better solutions for patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness the power of healthcare data, domain expertise, transformative technology, and advanced analytics to drive healthcare forward.

Post : PV Scientist

Pfizer Inc and Ionis Pharmaceuticals, Inc announced the discontinuation of the Pfizer-led clinical development program for vupanorsen (PF-07285557), an investigational antisense therapy that was being evaluated for potential indications in cardiovascular (CV) risk reduction and severe hypertriglyceridemia (SHTG).